Hyderabad Transforms into Premier Global Life Sciences Destination
In a remarkable evolution spanning just two and a half decades, Hyderabad has rapidly ascended from its renowned identity as the city of Charminar, biryani, pharmaceutical manufacturing, and software to become a preferred global hub for life sciences companies. Chief Minister A Revanth Reddy emphasized this transformative journey on Tuesday, highlighting Hyderabad's emergence as a critical center for establishing global capability centers (GCCs), building innovation engines, designing molecules and drugs, managing clinical analytics, developing AI platforms, and driving digital manufacturing.
Telangana's Strategic Vision Drives Global Recognition
Revanth Reddy attributed this success to Telangana's strong vision and clear policy framework, coupled with a deep talent pool and robust educational institutions. These factors have propelled the state to rank among the top life sciences hubs globally, attracting approximately Rs 73,000 crore in investments over the past few years alone. The Chief Minister made these remarks while inaugurating the 23rd edition of BioAsia, themed 'TechBio Unleashed,' in Hyderabad.
Describing Hyderabad as a trusted, stable, and future-ready ecosystem, Revanth noted that Telangana is strategically moving up the value chain—from bulk drugs to biologics and from traditional manufacturing to cutting-edge innovation. He pointed to the extensive international participation at BioAsia, suggesting that Asia's largest life sciences platform could soon be rebranded as BioWorld, a global forum with recognition comparable to the World Economic Forum held in Davos.
Ambitious Goals: $25 Billion Investments and 500,000 New Jobs
Industries and IT Minister D Sridhar Babu outlined Telangana's ambitious vision to develop Hyderabad as a laboratory of the future. The state aims to attract $25 billion in life sciences investments and generate 5 lakh new jobs by 2030. Sridhar Babu extended an invitation to global enterprises and investors to partner with Telangana, highlighting opportunities across several advanced domains:
- AI-based drug discovery
- Automation in biologics manufacturing
- Data-driven precision medicine
- Computational biology
- Bio-Manufacturing 4.0
He emphasized that India is no longer perceived merely as a supply base for pharmaceuticals and vaccines but is increasingly regarded as a source of advanced scientific solutions. Telangana is preparing for this shift—from a manufacturing base to a global centre for innovation, research, and advanced drug discovery, Sridhar Babu stated.
Next-Gen Policy and Global Rankings
The minister detailed the Next-Gen Life Sciences Policy (2026–2030), designed to position Telangana among the world's top three life sciences clusters by the end of this decade. This ambition is supported by Hyderabad's recent inclusion in the CBRE Global Life Sciences Atlas (2025), where it stands alongside established hubs such as Boston, San Francisco, Beijing, and Tokyo.
To bolster its research, innovation, and high-end manufacturing ecosystem, Telangana is implementing structured interventions. These include developing a future-ready workforce through institutions like the Telangana School of Life Sciences and Young India Skills University, which will provide specialized training in emerging areas such as:
- mRNA technology
- Gene editing
- AI-driven drug discovery
Additionally, the state has introduced a dedicated policy to establish Hyderabad as a global medical tourism hub, further expanding its influence in the healthcare and life sciences sectors.
This comprehensive strategy underscores Hyderabad's rapid transformation into a global epicenter for life sciences, driven by substantial investments, innovative policies, and a forward-looking approach to technology and research.
